Catalent Revenue 2012-2018 | CTLT

Catalent annual/quarterly revenue history and growth rate from 2012 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

Catalent revenue for the quarter ending December 31, 2018 was $0.623B, a 2.75% increase year-over-year.
Catalent revenue for the twelve months ending December 31, 2018 was $2.488B, a 8.19% increase year-over-year.
Catalent annual revenue for 2018 was $2.463B, a 18.7% increase from 2017.
Catalent annual revenue for 2017 was $2.075B, a 12.3% increase from 2016.
Catalent annual revenue for 2016 was $1.848B, a 0.94% increase from 2015.

Catalent Annual Revenue (Millions of US $)
2018	$2,463
2017	$2,075
2016	$1,848
2015	$1,831
2014	$1,828
2013	$1,800
2012	$1,695
2011	$1,532

Catalent Quarterly Revenue (Millions of US $)
Q2 2018	$623
Q1 2018	$552
Q4 2018	$685
Q3 2018	$628
Q2 2017	$606
Q1 2017	$544
Q4 2017	$617
Q3 2017	$533
Q2 2016	$484
Q1 2016	$442
Q4 2016	$532
Q3 2016	$438
Q2 2015	$455
Q1 2015	$423
Q4 2015	$510
Q3 2015	$447
Q2 2014	$456
Q1 2014	$418
Q4 2014	$520
Q3 2014	$453
Q2 2013	$441
Q1 2013	$414
Q4 2013	$0
Q3 2013	$0
Q4 2012	$0
Q4 2011	$0

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$6.403B	$2.463B
Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment address the full diversity of the pharmaceutical industry including small molecules, large molecule biologics and consumer health products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. Catalent, Inc. is headquartered in Somerset, New Jersey.

Stock Name	Country	Market Cap	PE Ratio
Zoetis (ZTS)	United States	$47.457B	31.54
Takeda Pharmaceutical (TAK)	Japan	$28.357B	10.49
Grifols (GRFS)	Spain	$12.830B	15.68
Ionis Pharmaceuticals (IONS)	United States	$10.102B	32.30
Sage Therapeutics (SAGE)	United States	$7.758B	0.00
Jazz Pharmaceuticals (JAZZ)	Ireland	$7.328B	10.49
Neurocrine Biosciences (NBIX)	United States	$7.158B	461.35
Nektar Therapeutics (NKTR)	United States	$5.516B	8.80
Tilray (TLRY)	United States	$4.740B	0.00
United Therapeutics (UTHR)	United States	$4.387B	7.46
Taro Pharmaceutical Industries (TARO)	Israel	$4.097B	13.19
FibroGen (FGEN)	United States	$4.039B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$3.793B	0.00
Portola Pharmaceuticals (PTLA)	United States	$2.252B	0.00
PTC Therapeutics (PTCT)	United States	$2.099B	0.00
USANA Health Sciences (USNA)	United States	$1.921B	16.12
Heron Therapeutics (HRTX)	United States	$1.837B	0.00
Aerie Pharmaceuticals (AERI)	United States	$1.799B	0.00
Xencor (XNCR)	United States	$1.765B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$1.738B	0.00
Arrowhead Pharmaceuticals (ARWR)	United States	$1.712B	0.00
Enanta Pharmaceuticals (ENTA)	United States	$1.668B	20.77
Madrigal Pharmaceuticals (MDGL)	United States	$1.627B	0.00
Endo (ENDP)	Ireland	$1.598B	2.46
Zogenix (ZGNX)	United States	$1.534B	0.00
Pacira Pharmaceuticals (PCRX)	United States	$1.518B	131.46
Corcept Therapeutics (CORT)	United States	$1.372B	19.93
Tricida (TCDA)	United States	$1.330B	0.00
Theravance Biopharma (TBPH)	Cayman Islands	$1.279B	0.00
Esperion Therapeutics (ESPR)	United States	$1.098B	0.00
Spectrum Pharmaceuticals (SPPI)	United States	$1.066B	0.00
TherapeuticsMD (TXMD)	United States	$1.020B	0.00
Radius Health (RDUS)	United States	$0.980B	0.00
BioCryst Pharmaceuticals (BCRX)	United States	$0.873B	0.00
Akebia Therapeutics (AKBA)	United States	$0.786B	0.00
CannTrust Holdings (CTST)	Canada	$0.751B	0.00
ArQule (ARQL)	United States	$0.713B	0.00
ChemoCentryx (CCXI)	United States	$0.700B	0.00
Dermira (DERM)	United States	$0.619B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$0.577B	0.00
Crinetics Pharmaceuticals (CRNX)	United States	$0.573B	0.00
Odonate Therapeutics (ODT)	United States	$0.573B	0.00
Forty Seven (FTSV)	United States	$0.559B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$0.546B	0.00
GlycoMimetics (GLYC)	United States	$0.523B	0.00
BioSpecifics Technologies Corp (BSTC)	United States	$0.460B	23.76
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.454B	0.00
Translate Bio (TBIO)	United States	$0.452B	0.00
Collegium Pharmaceutical (COLL)	United States	$0.451B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.440B	0.00
TCR2 THERAPTCS (TCRR)	United States	$0.439B	0.00
Siga Technologies (SIGA)	United States	$0.430B	0.00
OptiNose (OPTN)	United States	$0.408B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.396B	0.00
Flexion Therapeutics (FLXN)	United States	$0.388B	0.00
Aptorum Group (APM)	China	$0.388B	0.00
ImmunoGen (IMGN)	United States	$0.368B	0.00
Mast Therapeutics (SVRA)	United States	$0.334B	0.00
Harpoon Therapy (HARP)	United States	$0.317B	0.00
CASI Pharmaceuticals (CASI)	United States	$0.316B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.282B	0.00
Lannett Co Inc (LCI)	United States	$0.281B	2.61
ASSERTIO THERAPEUTICS, INC (ASRT)	United States	$0.276B	10.21
Minerva Neurosciences (NERV)	United States	$0.274B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.274B	0.00
AcelRx Pharmaceuticals (ACRX)	United States	$0.266B	0.00
Xeris Pharmaceuticals (XERS)	United States	$0.259B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.251B	0.00
Calithera Biosciences (CALA)	United States	$0.241B	0.00
Dova Pharmaceuticals (DOVA)	United States	$0.233B	0.00
Molecular Templates (MTEM)	United States	$0.231B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.228B	0.00
Concert Pharmaceuticals (CNCE)	United States	$0.222B	0.00
Ardelyx (ARDX)	United States	$0.212B	0.00
Affimed (AFMD)	Germany	$0.209B	0.00
MEI Pharma (MEIP)	United States	$0.208B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.204B	0.00
Marinus Pharmaceuticals (MRNS)	United States	$0.201B	0.00
Opexa Therapeutics (ACER)	United States	$0.200B	0.00
Galectin Therapeutics (GALT)	United States	$0.196B	0.00
La Jolla Pharmaceutical (LJPC)	United States	$0.194B	0.00
Taiwan Liposome, Unsponsored ADR (TLC)	Taiwan	$0.186B	0.00
Recro Pharma (REPH)	United States	$0.184B	0.00
Jounce Therapeutics (JNCE)	United States	$0.184B	0.00
Foamix Pharmaceuticals (FOMX)	Israel	$0.183B	0.00
Nature's Sunshine Products (NATR)	United States	$0.182B	189.00
ElectroCore (ECOR)	United States	$0.182B	0.00
Neon Therapeutics (NTGN)	United States	$0.177B	0.00
Majesco Entertainment (PTE)	United States	$0.174B	0.00
Redhill Biopharma (RDHL)	Israel	$0.172B	0.00
Aratana Therapeutics (PETX)	United States	$0.171B	0.00
IMV INC (IMV)	Canada	$0.170B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.168B	0.00
Tyme Technologies (TYME)	United States	$0.158B	0.00
Aquestive Therapeutics (AQST)	United States	$0.157B	0.00
Ocular Therapeutix (OCUL)	United States	$0.156B	0.00
Bellicum Pharmaceuticals (BLCM)	United States	$0.136B	0.00
MediWound (MDWD)	Israel	$0.132B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.119B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.114B	0.00
ProNAi Therapeutics (SRRA)	Canada	$0.109B	0.00
Cardiome Pharma (CORV)	Canada	$0.106B	0.00
Nivalis Therapeutics (ALPN)	United States	$0.105B	0.00
Natural Alternatives (NAII)	United States	$0.098B	9.62
Neos Therapeutics (NEOS)	United States	$0.097B	0.00
Zafgen (ZFGN)	United States	$0.097B	0.00
Oasmia Pharmaceutical AB (OASM)	Sweden	$0.094B	0.00
Adherex Technologies (FENC)	United States	$0.094B	0.00
DURECT (DRRX)	United States	$0.093B	0.00
Champions Oncology (CSBR)	United States	$0.092B	0.00
Adamis Pharmaceuticals (ADMP)	United States	$0.091B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.090B	0.00
Infinity Pharmaceuticals (INFI)	United States	$0.089B	0.00
Bio Blast Pharma (ENLV)	Israel	$0.083B	0.00
SCYNEXIS (SCYX)	United States	$0.083B	0.00
Otonomy (OTIC)	United States	$0.079B	0.00
Genocea Biosciences (GNCA)	United States	$0.078B	0.00
Avenue Therapeutics (ATXI)	United States	$0.075B	0.00
Entasis Therapeutics Holdings (ETTX)	United States	$0.072B	0.00
Capnia (SLNO)	United States	$0.064B	0.00
Tetraphase Pharmaceuticals (TTPH)	United States	$0.057B	0.00
CTI BioPharma (CTIC)	United States	$0.056B	0.00
Forward Pharma (FWP)	Denmark	$0.056B	0.00
Melinta Therapeutics (MLNT)	United States	$0.049B	0.00
Dipexium Pharmaceuticals (PLXP)	United States	$0.048B	0.00
Opiant Pharmaceuticals (OPNT)	United States	$0.048B	0.00
Bio-Path Holdings (BPTH)	United States	$0.048B	0.00
Lipocine (LPCN)	United States	$0.044B	0.00
KemPharm (KMPH)	United States	$0.043B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$0.043B	0.00
ContraFect (CFRX)	United States	$0.042B	0.00
Tokai Pharmaceuticals (NVUS)	United States	$0.040B	0.00
BioLineRx (BLRX)	Israel	$0.040B	0.00
Mannatechorporated (MTEX)	United States	$0.040B	0.00
Heat Biologics (HTBX)	United States	$0.038B	0.00
ProPhase Labs (PRPH)	United States	$0.035B	0.00
HANCOCK JAFFE (HJLI)	United States	$0.034B	0.00
Shineco (TYHT)	China	$0.029B	4.88
Summit Therapeutics (SMMT)	United Kingdom	$0.026B	3.47
PharmAthene (ALT)	United States	$0.025B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.024B	0.00
Jaguar Animal Health (JAGX)	United States	$0.024B	0.00
Achieve Life Sciences (ACHV)	United States	$0.024B	0.00
Biomerica (BMRA)	United States	$0.024B	0.00
Onconova Therapeutics (ONTX)	United States	$0.022B	0.00
CollPlant Holdings Sponsored ADR (CLGN)	Israel	$0.020B	0.00
NOVAN INC (NOVN)	United States	$0.020B	0.00
Cyanotech (CYAN)	United States	$0.020B	0.00
Pain Therapeutics (SAVA)	United States	$0.019B	0.00
Kitov Pharmaceuticals Holdings (KTOV)	Israel	$0.017B	0.00
Xenetic Biosciences (XBIO)	United States	$0.016B	0.00
ESSA Pharma (EPIX)	Canada	$0.015B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.014B	0.00
Eyegate Pharmaceuticals (EYEG)	United States	$0.013B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.013B	4.07
Regulus Therapeutics (RGLS)	United States	$0.012B	0.00
PRECISION THERAPEUTICS INC (AIPT)	United States	$0.012B	0.00
Achaogen (AKAO)	United States	$0.011B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.010B	0.00
RXi Pharmaceuticals (PHIO)	United States	$0.010B	0.00
DelMar Pharmaceuticals (DMPI)	Canada	$0.009B	0.00
Trillium Therapeutics (TRIL)	Canada	$0.009B	0.00
Ritter Pharmaceuticals (RTTR)	United States	$0.008B	0.00
Ohr Pharmaceuticals (OHRP)	United States	$0.006B	0.00
VAXART, INC (VXRT)	United States	$0.006B	0.00
Midatech Pharma (MTP)	United Kingdom	$0.006B	0.00
Advanced Accelerator Applications (AAAP)	France	$0.000B	0.00
Auris Medical Holding AG (EARS)	Switzerland	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00